could you shed a bit more light onto these? I never did structured products outside the EU and only traded those that I could find a replication by myself (e.g. options and NDFs). For me the biggest problem always was that the bank would cancel the trade once they figured they had mispriced the product.
It's actually prohibited to do so but you know...they have 200 lawyers and I have one. So I looked somewhere else.
Europe is different I think. In the US it’s only issued to private clients.
I was trading a lot of boosters. Basically 1x2 cost less callspreads with stock. The notes would have a downside buffer - which I couldn’t replicate myself. Basically for 5 years I was earning the SPX with 1/2 the capital and even less than that in risk until 2008, when the last note I traded busted. After that the levels weren’t very good.